Celecoxib Capsules
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Logistics Agency (DLA) Troop Support has awarded Radha Pharmaceuticals Inc. a Firm Fixed-Price contract (SPE2D2-26-D-0010) for Celecoxib Capsules, valued at $15,771,598.00. This award resulted from Solicitation SPE2D2-25-R-0021.
Scope of Work
This contract covers the procurement of various strengths and quantities of Celecoxib capsules, including:
- Celecoxib 50 MG Capsule (60 count)
- Celecoxib 100 MG Capsule (100 count)
- Celecoxib 100 MG Capsule (500 count)
- Celecoxib 200 MG Capsule (100 count)
- Celecoxib 200 MG Capsule (500 count)
- Celecoxib 400 MG Capsule (60 count)
Contract & Timeline
- Contract Number: SPE2D2-26-D-0010
- Type: Firm Fixed-Price
- Duration: Estimated 5 years
- Value: $15,771,598.00
- Set-Aside: Unrestricted
- Award Date: June 21, 2026
- Original Solicitation: SPE2D2-25-R-0021
Award Details
The contract was awarded to Radha Pharmaceuticals Inc. based on the "lowest price technically acceptable" offer. Final Proposal Revisions for the original solicitation were opened on January 20, 2025.
Additional Notes
The acquisition falls under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) with a size standard of 1300 employees. The contract incorporates various FAR clauses by reference.